Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Self-reported health promotion and disability progression in multiple sclerosis.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Regulation of claudins in blood-tissue barriers under physiological and pathological states.
The axes of access--improving care for patients with disabilities.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Prognostic factors of acute partial transverse myelitis.

Pages